A Quantitative Nomogram Integrating IVIM-derived True Diffusion Coefficient and PSAD for Predicting Clinically Significant Prostate Cancer: Comparison With PI-RADS-based Assessment.
The PSAD + D nomogram achieves diagnostic performance comparable to PI-RADS + PSAD for predicting csPCa while eliminating reader dependency through objective, highly reproducible parameters (intraclass correlation coefficients).
Abstract
Rationale
AND
Objectives
To develop and validate a quantitative nomogram integrating the intravoxel incoherent motion (IVIM)-derived true diffusion coefficient (D) and prostate-specific antigen density (PSAD) for predicting clinically significant prostate cancer (csPCa) in patients with elevated serum PSA, and to compare its diagnostic performance with that of Prostate Imaging Reporting and Data System (PI-RADS)-based assessment.
Materials And Methods
This combined retrospective and prospective study enrolled 341 patients (total PSA > 4 ng/mL) who underwent prostate magnetic resonance imaging incorporating IVIM-diffusion-weighted imaging and subsequent pathological confirmation. The retrospective cohort (n = 253) was randomly split into training (n = 176) and internal validation (n = 77) sets; an independent prospective cohort (n = 88) served as the temporal validation set. csPCa was defined as a Gleason score ≥7. Independent predictors were identified from IVIM-derived parameters (D, D*, f), conventional apparent diffusion coefficient (ADC), and PSA-derived indices using multivariate logistic regression. Models of increasing complexity were constructed, and the optimal parameter combination was determined. Diagnostic performance was compared using the area under the receiver operating characteristic curve (AUC), the DeLong test, net reclassification improvement, integrated discrimination improvement (IDI), and decision curve analysis (DCA). PI-RADS alone and PI-RADS + PSAD served as reference comparators.
Results
PSAD, ADC, and D were identified as independent predictors of csPCa. The PSAD + D model achieved AUCs of 0.920, 0.900, and 0.916 in the training, validation, and prospective sets, respectively; PSAD + ADC + D yielded AUCs of 0.923, 0.877, and 0.917; and PI-RADS + PSAD achieved 0.903, 0.919, and 0.936. The DeLong test revealed no significant differences among the three models in any dataset (all false discovery rate-corrected p > 0.05). IDI analysis demonstrated that incorporating ADC into the PSAD + D model resulted in significantly negative discrimination improvement across all three datasets.
Conclusion
The PSAD + D nomogram achieves diagnostic performance comparable to PI-RADS + PSAD for predicting csPCa while eliminating reader dependency through objective, highly reproducible parameters (intraclass correlation coefficients: 0.93-0.96). The paradoxical performance attenuation upon ADC addition demonstrates that parameter parsimony, rather than dimensionality maximization, optimizes predictive accuracy in quantitative imaging models.
The apparent diffusion coefficient-based radiomics model effectively detected csPCa in PI-RADS 3 lesions in the training set and demonstrated moderate performance in the external validation set.
G. Gao, Ke-Xin Wang, Xiao-Ying Wang et al.· Academic Radiology· 0 citations
ADC radiomics provided complementary information for differentiating benign and malignant PI-RADS 3-5 prostate lesions, but its incremental value beyond the clinical model was limited.
Shu-Man Du, Shu-Ren Du, Shu-Yan Mei et al.· International Urology and Ne...· 0 citations
Introduction: Multiparametric MRI (mpMRI) interpreted using Prostate Imaging Reporting and Data System (PI-RADS) v2.1 is central to prostate cancer (PCa) assessment, but inter-reader variability remains a concern. This study evaluated inter-reader agreement, diagnostic performance, the utility of prostate-specific anti...
M. Abufaraj, Sarah B. Al-Qalalweh, Ahmad S. Kreishan et al.· Diagnostics· 0 citations
Background Apparent diffusion coefficient (ADC) derived from diffusion-weighted imaging (DWI) has been proposed as a quantitative biomarker of prostate cancer aggressiveness, and an inverse relationship between ADC and Gleason score has been reported across numerous single-marker studies and meta-analyses. However, mos...
K. Skrobisz, Weronika Bernard, Rafał Bromirski et al.· Frontiers in Oncology· 0 citations
PURPOSE
To determine whether three-level transrectal ultrasound (TRUS) target visibility adds predictive information beyond clinical and magnetic resonance imaging (MRI) variables for patient-level biopsy-detected clinically significant prostate cancer (csPCa).
MATERIALS AND METHODS
This retrospective two-center stud...
Xiu-Bin Tang, Ming Chen, You-Hai Wu et al.· European Journal of Radiolog...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.